Sulfasalazine-induced angioimmunoblastic lymphadenopathy developing in a patient with juvenile chronic arthritis.
作者信息
Pay S, Dinc A, Simsek I, Can C, Erdem H
机构信息
GATA Romatoloji Bilim Dah, Etlik, Ankara, Turkey.
出版信息
Rheumatol Int. 2000 Dec;20(1):25-7. doi: 10.1007/s002960000056.
PMID:11149657
Abstract
We describe a patient with juvenile chronic arthritis who developed reactive angioimmunoblastic lymphadenopathy, induced by sulfasalazine. Development of angioimmunoblastic lymphadenopathy although rare, is a very serious side effect of sulfasalazine treatment, and patients treated with this drug should be watched carefully.
摘要
Zotero 插件